Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: KD Treatment for Super-refractory Status Epilepticus [NA]

View source ↗

Summary

A clinical trial is evaluating ketogenic-diet therapy for super-refractory status epilepticus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Super-refractory Status Epilepticus | NA | Status: RECRUITING